Biotech

All Articles

MBX goes for $136M IPO to take rival to Ascendis in to stage 3

.MBX has fleshed out plans to take in over $136 thousand from its IPO as the biotech hopes to bring ...

Relay breast cancer records tee up encounter AstraZeneca's Truqap

.Relay Therapies has actually beaten its own survival goal in a first-in-human bust cancer cells res...

AZ details AI-enabled TROP2 biomarker strategy for Daiichi ADC

.AstraZeneca has actually utilized expert system to design a distinct biomarker for its own Daiichi ...

AstraZeneca IL-33 medication neglects to strengthen COPD breathing in ph. 2

.AstraZeneca execs state they are actually "certainly not worried" that the failure of tozorakimab i...

BMS vet responses Foghorn's require CBO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of substantial leadership hirings, firings ...

Zenas, Bicara laid out to raise $180M-plus in distinct IPOs

.After revealing strategies to attack the USA public markets less than a month back, Zenas Biopharma...

Psyence obtains fellow psilocybin biotech Clairvoyant

.Psyence Biomedical is actually paying $500,000 in portions to acquire fellow psilocybin-based biote...